...
首页> 外文期刊>Journal of Agricultural and Food Chemistry >Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and Losartan
【24h】

Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and Losartan

机译:通过微孔板测定法测量血管紧张素-I转换酶的抑制活性:使用海洋肽的比较以及卡托普利和氯沙坦的初步阈值测定

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the angiotensin-I converting enzyme (ACE) inhibitory activity of marine cryptides, different methods were tested. ACE inhibition was measured using two synthetic substrates, (N-[3-(2-furyl) acryloyl]-Phe-Gly-Gly (FAPGG) and N-hippuryl-His-Leu hydrate salt (HHL)), and a natural one, angiotensin-I. The IC_(50) value (denned as the concentration of inhibitory molecule needed to inhibit 50% of the ACE activity) of the reference synthetic inhibitor captopril was in the nanomolar range (1.79—15.1 nM) when synthetic substrates were used, whereas it exhibited IC_(50) of micromolar range (16.71 μM) with angiotensin-I. We chose losartan, an antagonist of angiotensin-II receptor as negative control for the ACE inhibition. Losartan was also able to inhibit ACE whatever the substrate tested, with IC_(50) of micromolar range (17.13-146 μM). We denned this value as a limit above which molecules are not showing in vitro ACE inhibitory activity. Val-Trp (VW), Val-Tyr (VY), Lys-Tyr (ICY), Lys-Trp (KW), Ile-Tyr (IY), Ala-Pro (AP), Val-Ile-Tyr (VIY), Leu-Lys-Pro (LKP), Gly-Pro-Leu (GPL), Ala-Lys-Lys (AKK), and Val-Ala-Pro (VAP) were tested as inhibitors of ACE with synthetic and natural substrates. IC_(50) displayed were substrate-dependent. With FAPGG as substrate, IW, VAP, ICY, IY, AP, AKK, and VIY show IC_(50) values over the IC_(50) value of losartan and should not be considered as inhibitors of ACE. VY, VW, ICW, and LKP exhibited IC_(50) value lower than the IC_(50) value of losartan for all substrates tested and were thus considered as good candidates for effectively decreasing hypertension. It appears that the comparison of IC_(50) is not consistent when IC_(50) values are obtained with different substrates and different methods. In vitro ACE inhibitory activity assays should always include various ACE substrates and references such as captopril and a negative control to obtain data reliable to discriminate ACE inhibitory peptides.
机译:为了确定海洋隐蛋白的血管紧张素转换酶(ACE)抑制活性,测试了不同的方法。使用两种合成底物(N- [3-(2-呋喃基)丙烯酰基] -Phe-Gly-Gly(FAPGG)和N-乙酰基-His-Leu水合物盐(HHL))测量ACE抑制,血管紧张素I。当使用合成底物时,参考合成抑制剂卡托普利的IC_(50)值(定义为抑制50%ACE活性所需的抑制分子的浓度)在纳摩尔范围内(1.79-15.1 nM),但显示具有血管紧张素-I的微摩尔范围(16.71μM)的IC_(50)。我们选择血管紧张素II受体拮抗剂氯沙坦作为ACE抑制的阴性对照。氯沙坦还能够抑制ACE,无论所测试的底物如何,IC_(50)的微摩尔范围(17.13-146μM)。我们将此值定义为一个极限值,在该极限值之上,分子未显示出体外ACE抑制活性。 Val-Trp(VW),Val-Tyr(VY),Lys-Tyr(ICY),Lys-Trp(KW),Ile-Tyr(IY),Ala-Pro(AP),Val-Ile-Tyr(VIY)分别测试了Leu-Lys-Pro(LKP),Gly-Pro-Leu(GPL),Ala-Lys-Lys(AKK)和Val-Ala-Pro(VAP)作为具有合成和天然底物的ACE抑制剂。显示的IC_(50)取决于底物。以FAPGG为底物,IW,VAP,ICY,IY,AP,AKK和VIY显示的IC_(50)值超过氯沙坦的IC_(50)值,因此不应视为ACE抑制剂。对于所有测试的底物,VY,VW,ICW和LKP的IC_(50)值均低于氯沙坦的IC_(50)值,因此被认为是有效降低高血压的良好候选者。当使用不同的基板和不同的方法获得IC_(50)值时,IC_(50)的比较似乎不一致。体外ACE抑制活性测定应始终包括各种ACE底物和参考,例如卡托普利和阴性对照,以获得可靠的数据来区分ACE抑制肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号